标题: Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b .. [打印本页] 作者: StephenW 时间: 2011-3-30 22:02 标题: Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b ..
Mar. 30, 2011 (Business Wire) -- Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
2011年3月30号（商业新闻） -普雷西迪奥制药公司今天宣布，从一个积极的1b期临床试验的生产者价格指数- 461，一种新型的丙型肝炎病毒NS5A对患者治疗慢性丙型肝炎抑制剂的初步结果